Anderson Kenneth Carl 4

4 · C4 Therapeutics, Inc. · Filed Jan 6, 2023

Form 4

Period: 2023-01-06

Director

Transactions

Exercise/Conversion
Common Stock
2023-01-06$2.11/sh+268$565→ 94,684 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-01-06−268→ 1,067 total
Exercise: $2.11Exp: 2026-07-12→ Common Stock (268 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-01-06−444→ 890 total
Exercise: $4.98Exp: 2030-07-02→ Common Stock (444 underlying)
Exercise/Conversion
Common Stock
2023-01-06$4.98/sh+444$2,211→ 95,128 total

Holdings

Footnotes (6)

[F1]Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F2]Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F3]Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F4]Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F5]12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.
[F6]The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.

Documents

1 file